More on RXST

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-24.1% Growth)
- Ratings (0.8 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

RxSight (NQ:RXST)
Delayed: 5.55 -0.02 (0.36%)
Prev. Close $5.57  
Open$5.48 
52 Wk High$ 
52 Wk Low$ 
Day High$5.73 
Day Low$5.38 
P/E N/A  
EPS$ 
Volume839,213 

Friends, Peers and Foes (?): KMTS, NSPR, AXNX, ANRO, LAZR (more...)

Jul 17, 2026 11:34 AM Form SCHEDULE 13G RxSight, Inc. Filed by: BlackRock Portfolio Management LLC
Jul 15, 2026 04:24 PM Form 8-K RxSight, Inc. For: Jul 13
Jul 15, 2026 04:15 PM RxSight names Mottiwala as CEO, Kurtz shifts to chief medical officer
Jul 15, 2026 04:15 PM RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
Jul 7, 2026 12:24 PM RxSight Inc. (RXST) PT Lowered to $6.50 at BofA Securities
Jul 7, 2026 06:56 AM RxSight (RXST) Reiterated at Hold by Stifel as ALC Collaboration Announced
Jul 6, 2026 04:16 PM Alcon and RxSight team up to develop light-adjustable cataract lenses
Jul 6, 2026 04:15 PM Form 8-K RxSight, Inc. For: Jul 06
Jul 6, 2026 04:15 PM RxSight cuts 2026 sales outlook, citing competitive headwinds
Jul 6, 2026 04:15 PM Form 8-K RxSight, Inc. For: Jun 30
View All Articles

Entities mentioned with RXST

View All Entities